Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors

Kwang Min Woo1, M Abdallah Mahrous1, Donald J D'Amico1

  • 1Department of Ophthalmology, Weill Cornell Medical College, 1305 York Avenue, 11Th Floor, New York, NY, 10021, USA.

Abstract

Insights

This study found no significant association between antiretroviral therapy (zidovudine, lamivudine, abacavir) and age-related macular degeneration (ARMD) in HIV patients. Further research with larger cohorts is recommended for definitive conclusions on ARMD subtypes.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Infectious Diseases

Background:

  • P2X7 receptor (P2X7R) activation is implicated in age-related macular degeneration (ARMD).
  • Nucleoside reverse transcriptase inhibitors (NRTIs) like zidovudine (AZT), lamivudine (3TC), and abacavir (ABC) inhibit P2X7R and show promise in animal models of ARMD.

Purpose of the Study:

  • To investigate the clinical association between chronic NRTI therapy (AZT, 3TC, ABC) and ARMD.
  • To determine if P2X7R-inhibiting antiretrovirals impact ARMD prevalence in HIV patients.

Main Methods:

  • Retrospective cohort study comparing HIV patients with and without NRTI use, and non-HIV controls.
  • Fundus examination and spectral domain optical coherence tomography (SD-ODT) used to assess ARMD prevalence.

Main Results:

  • No statistically significant difference in early-intermediate ARMD prevalence between HIV patients with and without NRTI history (p=0.887).
  • No significant difference in geographic atrophy or exudative ARMD prevalence between HIV patients with NRTI history and non-HIV controls.

Conclusions:

  • Chronic use of AZT, 3TC, and ABC did not show a significant effect on early-intermediate ARMD, geographic atrophy, or exudative ARMD in this cohort.
  • Larger studies with detailed medication histories are necessary to confirm these findings, particularly for geographic atrophy and exudative ARMD.

Related Concept Videos